| UNITED THERAPEUTICS |
| USA |
| Gesundheit |
| US91307C1027 / 923818 |
| UTH (Frankfurt) / UTHR (NASDAQ) |
| FRA:UTH, ETR:UTH, UTH:GR, NASDAQ:UTHR |
| - |
| http://www.unither.com/ |
|
United Therapeutics Corp. is a biotechnology company focused on developing and commercializing medicines for patients with serious, chronic, and life-threatening diseases. Its portfolio centers on therapies for pulmonary arterial hypertension, includ..
>Volltext.. |
| 18978.79 Mio. EUR |
| 16646.59 Mio. EUR |
| 2722.53 Mio. EUR |
| 1290.19 Mio. EUR |
| 1131.39 Mio. EUR |
| 26.14 EUR |
| - |
| 1377.27 Mio. EUR |
| 1451.5 Mio. EUR |
| 4.38 |
| 5.72% |
| 8.86% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 96.474.919 Euro. |
| UNITED THERAPEUTICS, UNITED THERAPEUTIC, UNITED THERA |
| 03.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|